清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Relationship between postoperative nodal skip metastasis of mid-thoracic esophageal squamous cell carcinoma and patient prognosis and its value in guiding postoperative adjuvant treatment

医学 食管鳞状细胞癌 倾向得分匹配 佐剂 阶段(地层学) 淋巴结 放射治疗 肿瘤科 内科学 转移 淋巴 辅助治疗 多元分析 化疗 癌症 病理 古生物学 生物
作者
Hongmei Gao,Xiaohan Zhao,Wenbin Shen,Youmei Li,Shuguang Li,Shu-Chai Zhu
出处
期刊:Frontiers in Surgery [Frontiers Media SA]
卷期号:9 被引量:1
标识
DOI:10.3389/fsurg.2022.1038731
摘要

To evaluate the predictive role of nodal skip metastasis (NSM) in the prognosis of lymph node-positive mid-thoracic esophageal squamous cell carcinoma, and to evaluate the significance of postoperative adjuvant treatment in patients with different sites of metastatic nodes.A retrospective analysis was performed on clinical data of 321 lymph node-positive mid-thoracic esophageal squamous cell carcinoma patients who underwent surgery in the Fourth Hospital of Hebei Medical University. Based on the site and condition of lymph node metastasis by postoperative pathology, the patients were divided into two groups: NSM group and non-NSM (NNSM) group. The propensity score matching (PSM) method was employed to match the two groups. The prognostic factors of patients before and after PSM as well as the effect of different adjuvant treatment modes on the prognosis of patients before and after PSM were analyzed. SPSS 29.0 statistical software was used for analysis.PSM in a 1 : 1 matching ratio was performed, 103 patients were assigned to NSM group and NNSM group respectively. Significant differences were found in the 3- and 5-year OS and DFS between the two groups before PSM, the 3- and 5-year OS also showed a significant difference after PSM (P < 0.05). Multivariate analysis illustrated that gender, postoperative adjuvant treatment mode, N stage and lymph node metastasis were independent risk factors for OS and DFS after PSM (P < 0.05); for NSM patients, postoperative adjuvant chemotherapy and radiotherapy significantly prolonged OS and DFS before and after PSM (P < 0.05). But no significant difference was found in OS and DFS for NNSM patients after PSM (P > 0.05).Postoperative NSM is a good prognostic factor for patients with mid-thoracic esophageal squamous cell carcinoma, postoperative adjuvant chemoradiotherapy was recommended for those group, thereby gaining survival benefits.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pluto应助hh0采纳,获得10
19秒前
未来可期完成签到,获得积分10
24秒前
冬去春来完成签到 ,获得积分10
34秒前
DJ_Tokyo完成签到,获得积分10
44秒前
科研通AI2S应助hh0采纳,获得10
54秒前
arsenal完成签到 ,获得积分10
59秒前
pluto应助hh0采纳,获得10
1分钟前
Eri_SCI完成签到 ,获得积分10
1分钟前
yy2023应助hh0采纳,获得10
1分钟前
无悔完成签到 ,获得积分10
1分钟前
美丽依波完成签到 ,获得积分10
1分钟前
俗人应助hh0采纳,获得10
1分钟前
科研通AI2S应助hh0采纳,获得10
2分钟前
Owen应助科研通管家采纳,获得10
2分钟前
2分钟前
俗人应助hh0采纳,获得10
3分钟前
gwbk完成签到,获得积分10
3分钟前
heisa完成签到,获得积分10
3分钟前
3分钟前
科研通AI2S应助hh0采纳,获得10
3分钟前
科研通AI2S应助hh0采纳,获得10
3分钟前
房天川完成签到 ,获得积分10
3分钟前
ee_Liu完成签到,获得积分10
3分钟前
科研通AI2S应助hh0采纳,获得10
3分钟前
renpp822发布了新的文献求助10
4分钟前
doreen完成签到 ,获得积分10
4分钟前
vsvsgo完成签到,获得积分10
4分钟前
烟消云散完成签到,获得积分10
4分钟前
pluto应助hh0采纳,获得10
4分钟前
zmuzhang2019完成签到,获得积分10
4分钟前
pluto应助hh0采纳,获得10
4分钟前
科研通AI2S应助hh0采纳,获得10
5分钟前
Richard完成签到 ,获得积分10
5分钟前
guoguo1119完成签到 ,获得积分10
6分钟前
小小aa16完成签到,获得积分10
6分钟前
章鱼完成签到,获得积分10
7分钟前
7分钟前
隐形问萍发布了新的文献求助30
8分钟前
隐形问萍发布了新的文献求助10
8分钟前
oaoalaa完成签到 ,获得积分10
8分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
The late Devonian Standard Conodont Zonation 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
Zeitschrift für Orient-Archäologie 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3239003
求助须知:如何正确求助?哪些是违规求助? 2884295
关于积分的说明 8232922
捐赠科研通 2552338
什么是DOI,文献DOI怎么找? 1380690
科研通“疑难数据库(出版商)”最低求助积分说明 649071
邀请新用户注册赠送积分活动 624769